Creation and Psychometric Validation of the Sexual Minorities and Prostate Cancer Scale (SMACS) in Sexual Minority Patients-The Restore-2 Study

Existing measures of sexual functioning in prostate cancer survivors focus primarily on erectile function and do not adequately measure the experiences of sexual minority men. To develop and psychometrically evaluate a new scale to measure sexual functioning among sexual minority men with prostate c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of sexual medicine 2022-03, Vol.19 (3), p.529-540
Hauptverfasser: Polter, Elizabeth J., Kohli, Nidhi, Rosser, B.R. Simon, Talley, Kristine M.C., Wheldon, Christopher W., Hoefer, Chris J., Wright, Morgan, Haggart, Ryan, Mitteldorf, Darry, Kilian, Gudrun, Konety, Badrinath R., Ross, Michael W., West, William
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 540
container_issue 3
container_start_page 529
container_title Journal of sexual medicine
container_volume 19
creator Polter, Elizabeth J.
Kohli, Nidhi
Rosser, B.R. Simon
Talley, Kristine M.C.
Wheldon, Christopher W.
Hoefer, Chris J.
Wright, Morgan
Haggart, Ryan
Mitteldorf, Darry
Kilian, Gudrun
Konety, Badrinath R.
Ross, Michael W.
West, William
description Existing measures of sexual functioning in prostate cancer survivors focus primarily on erectile function and do not adequately measure the experiences of sexual minority men. To develop and psychometrically evaluate a new scale to measure sexual functioning among sexual minority men with prostate cancer. Sexual minority prostate cancer patients (n = 401) completed an online battery of urinary and sexual functioning tests in 2019, including a new 37-item instrument about their sexual functioning post-treatment for prostate cancer. We used confirmatory factor analysis to determine the construct validity of a new scale including five subscales: a four-factor model for all participants (n = 401) evaluated Sexual Satisfaction, Sexual Confidence, Frequency of Sexual Problems, and Urinary Incontinence in Sex. A single-factor model completed only by participants who had attempted or desired receptive anal sex (n = 255) was evaluated in the fifth subscale: Problematic Receptive Anal Sex. To evaluate criterion validity, we calculated the intercorrelations between each Sexual Minorities and Prostate Cancer Scale (SMACS) subscale and four related scales: the Expanded Prostate Cancer Index Composite-50 (EPIC), the Functional Assessment of Cancer Therapy-Prostate, the Brief Symptom Inventory-18, and the International Consultation on incontinence questionnaire. Cronbach's alphas were calculated to measure internal consistency (ie, reliability). Cronbach's alpha values ranged from 0.64 to 0.89. Loadings (0.479–0.926) and model fit indices were strong (Root Mean Square Error of Approximation: 0.085, Standardized root mean squared residual: 0.063, comparative fit index: 0.927, Tucker-Lewis Index: 0.907). For criterion validity, Sexual Satisfaction, Sexual Confidence, and Frequency of Sexual Problems were moderately correlated with EPIC function and bother scores (r = 0.50–0.72) and Urinary incontinence in sex correlated moderately with EPIC Urinary Function and International Consultation on incontinence questionnaire scores (0.45–0.56). The SMACS can be used by clinicians and researchers to comprehensively measure sexual functioning in sexual minority men, in conjunction with existing scales. This new scale is validated in a large, geographically diverse cohort of sexual minority cancer survivors and fills an important gap in existing measures of sexual functioning. Limitations include a lack of a validation sample. The SMACS is a valid and reliable new scale that measures
doi_str_mv 10.1016/j.jsxm.2021.12.012
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8893317</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1743609521008328</els_id><sourcerecordid>2626890131</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-77b39eb54eb29803665992df701f3e0b30d73c02278840b86091eae7e0e4b3a3</originalsourceid><addsrcrecordid>eNp9kctq3DAYhUVpaC7tC2RRtEwWdnXxTRAKwTRNIKGhHroVsvw7o8G2EkkOmafoK1eDk9BmUW0k-M_5JJ2D0DElKSW0-LJJN_5pTBlhNKUsJZS9Qwe0zHhSUCLev5yJyPfRofcbQnhc7APa5znllApxgH7XDlQwdsJq6vCt3-q1HSE4o_EvNZhumdkehzXgBp5mNeAbM1lnggG_mJz1QQXAtZo0ONxoNQA-aW7O6-YUm-mNbYtvIxSm4JNVZP4EH6yDhOEmzN32I9rr1eDh0_N-hFYX31b1ZXL94_tVfX6d6CzPQ1KWLRfQ5hm0TFSEF0UuBOv6ktCeA2k56UquCWNlVWWkrWIIFBSUQCBrueJH6OuCvZ_bETodn-PUIO-dGZXbSquM_HcymbW8s4-yqgTntIyAk2eAsw9z_IMcjdcwDGoCO3vJClZUgsSYo5QtUh2D8g7612sokbsi5UbuipS7IiVlMhYZTZ__fuCr5aW5KDhbBBBTejTgpNcxVQ2dcaCD7Kz5H_8PYj6w7Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2626890131</pqid></control><display><type>article</type><title>Creation and Psychometric Validation of the Sexual Minorities and Prostate Cancer Scale (SMACS) in Sexual Minority Patients-The Restore-2 Study</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><creator>Polter, Elizabeth J. ; Kohli, Nidhi ; Rosser, B.R. Simon ; Talley, Kristine M.C. ; Wheldon, Christopher W. ; Hoefer, Chris J. ; Wright, Morgan ; Haggart, Ryan ; Mitteldorf, Darry ; Kilian, Gudrun ; Konety, Badrinath R. ; Ross, Michael W. ; West, William</creator><creatorcontrib>Polter, Elizabeth J. ; Kohli, Nidhi ; Rosser, B.R. Simon ; Talley, Kristine M.C. ; Wheldon, Christopher W. ; Hoefer, Chris J. ; Wright, Morgan ; Haggart, Ryan ; Mitteldorf, Darry ; Kilian, Gudrun ; Konety, Badrinath R. ; Ross, Michael W. ; West, William</creatorcontrib><description>Existing measures of sexual functioning in prostate cancer survivors focus primarily on erectile function and do not adequately measure the experiences of sexual minority men. To develop and psychometrically evaluate a new scale to measure sexual functioning among sexual minority men with prostate cancer. Sexual minority prostate cancer patients (n = 401) completed an online battery of urinary and sexual functioning tests in 2019, including a new 37-item instrument about their sexual functioning post-treatment for prostate cancer. We used confirmatory factor analysis to determine the construct validity of a new scale including five subscales: a four-factor model for all participants (n = 401) evaluated Sexual Satisfaction, Sexual Confidence, Frequency of Sexual Problems, and Urinary Incontinence in Sex. A single-factor model completed only by participants who had attempted or desired receptive anal sex (n = 255) was evaluated in the fifth subscale: Problematic Receptive Anal Sex. To evaluate criterion validity, we calculated the intercorrelations between each Sexual Minorities and Prostate Cancer Scale (SMACS) subscale and four related scales: the Expanded Prostate Cancer Index Composite-50 (EPIC), the Functional Assessment of Cancer Therapy-Prostate, the Brief Symptom Inventory-18, and the International Consultation on incontinence questionnaire. Cronbach's alphas were calculated to measure internal consistency (ie, reliability). Cronbach's alpha values ranged from 0.64 to 0.89. Loadings (0.479–0.926) and model fit indices were strong (Root Mean Square Error of Approximation: 0.085, Standardized root mean squared residual: 0.063, comparative fit index: 0.927, Tucker-Lewis Index: 0.907). For criterion validity, Sexual Satisfaction, Sexual Confidence, and Frequency of Sexual Problems were moderately correlated with EPIC function and bother scores (r = 0.50–0.72) and Urinary incontinence in sex correlated moderately with EPIC Urinary Function and International Consultation on incontinence questionnaire scores (0.45–0.56). The SMACS can be used by clinicians and researchers to comprehensively measure sexual functioning in sexual minority men, in conjunction with existing scales. This new scale is validated in a large, geographically diverse cohort of sexual minority cancer survivors and fills an important gap in existing measures of sexual functioning. Limitations include a lack of a validation sample. The SMACS is a valid and reliable new scale that measures sexual minority men's experience of urinary incontinence in sex, problematic receptive anal sex, and sexual distress. Polter EJ, Kohli N, Rosser BRS, et al. Creation and Psychometric Validation of the Sexual Minorities and Prostate Cancer Scale (SMACS) in Sexual Minority Patients-The Restore-2 Study. J Sex Med 2022;19:529–540.</description><identifier>ISSN: 1743-6095</identifier><identifier>EISSN: 1743-6109</identifier><identifier>DOI: 10.1016/j.jsxm.2021.12.012</identifier><identifier>PMID: 35131199</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Humans ; Male ; Men ; Prostate Cancer ; Prostatic Neoplasms - diagnosis ; Psychometric ; Psychometrics ; Quality of Life ; Reproducibility of Results ; Sexual and Gender Minorities ; Sexual Dysfunction, Urinary Incontinence ; Surveys and Questionnaires</subject><ispartof>Journal of sexual medicine, 2022-03, Vol.19 (3), p.529-540</ispartof><rights>2022 International Society for Sexual Medicine</rights><rights>Copyright © 2022 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-77b39eb54eb29803665992df701f3e0b30d73c02278840b86091eae7e0e4b3a3</citedby><cites>FETCH-LOGICAL-c455t-77b39eb54eb29803665992df701f3e0b30d73c02278840b86091eae7e0e4b3a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35131199$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Polter, Elizabeth J.</creatorcontrib><creatorcontrib>Kohli, Nidhi</creatorcontrib><creatorcontrib>Rosser, B.R. Simon</creatorcontrib><creatorcontrib>Talley, Kristine M.C.</creatorcontrib><creatorcontrib>Wheldon, Christopher W.</creatorcontrib><creatorcontrib>Hoefer, Chris J.</creatorcontrib><creatorcontrib>Wright, Morgan</creatorcontrib><creatorcontrib>Haggart, Ryan</creatorcontrib><creatorcontrib>Mitteldorf, Darry</creatorcontrib><creatorcontrib>Kilian, Gudrun</creatorcontrib><creatorcontrib>Konety, Badrinath R.</creatorcontrib><creatorcontrib>Ross, Michael W.</creatorcontrib><creatorcontrib>West, William</creatorcontrib><title>Creation and Psychometric Validation of the Sexual Minorities and Prostate Cancer Scale (SMACS) in Sexual Minority Patients-The Restore-2 Study</title><title>Journal of sexual medicine</title><addtitle>J Sex Med</addtitle><description>Existing measures of sexual functioning in prostate cancer survivors focus primarily on erectile function and do not adequately measure the experiences of sexual minority men. To develop and psychometrically evaluate a new scale to measure sexual functioning among sexual minority men with prostate cancer. Sexual minority prostate cancer patients (n = 401) completed an online battery of urinary and sexual functioning tests in 2019, including a new 37-item instrument about their sexual functioning post-treatment for prostate cancer. We used confirmatory factor analysis to determine the construct validity of a new scale including five subscales: a four-factor model for all participants (n = 401) evaluated Sexual Satisfaction, Sexual Confidence, Frequency of Sexual Problems, and Urinary Incontinence in Sex. A single-factor model completed only by participants who had attempted or desired receptive anal sex (n = 255) was evaluated in the fifth subscale: Problematic Receptive Anal Sex. To evaluate criterion validity, we calculated the intercorrelations between each Sexual Minorities and Prostate Cancer Scale (SMACS) subscale and four related scales: the Expanded Prostate Cancer Index Composite-50 (EPIC), the Functional Assessment of Cancer Therapy-Prostate, the Brief Symptom Inventory-18, and the International Consultation on incontinence questionnaire. Cronbach's alphas were calculated to measure internal consistency (ie, reliability). Cronbach's alpha values ranged from 0.64 to 0.89. Loadings (0.479–0.926) and model fit indices were strong (Root Mean Square Error of Approximation: 0.085, Standardized root mean squared residual: 0.063, comparative fit index: 0.927, Tucker-Lewis Index: 0.907). For criterion validity, Sexual Satisfaction, Sexual Confidence, and Frequency of Sexual Problems were moderately correlated with EPIC function and bother scores (r = 0.50–0.72) and Urinary incontinence in sex correlated moderately with EPIC Urinary Function and International Consultation on incontinence questionnaire scores (0.45–0.56). The SMACS can be used by clinicians and researchers to comprehensively measure sexual functioning in sexual minority men, in conjunction with existing scales. This new scale is validated in a large, geographically diverse cohort of sexual minority cancer survivors and fills an important gap in existing measures of sexual functioning. Limitations include a lack of a validation sample. The SMACS is a valid and reliable new scale that measures sexual minority men's experience of urinary incontinence in sex, problematic receptive anal sex, and sexual distress. Polter EJ, Kohli N, Rosser BRS, et al. Creation and Psychometric Validation of the Sexual Minorities and Prostate Cancer Scale (SMACS) in Sexual Minority Patients-The Restore-2 Study. J Sex Med 2022;19:529–540.</description><subject>Humans</subject><subject>Male</subject><subject>Men</subject><subject>Prostate Cancer</subject><subject>Prostatic Neoplasms - diagnosis</subject><subject>Psychometric</subject><subject>Psychometrics</subject><subject>Quality of Life</subject><subject>Reproducibility of Results</subject><subject>Sexual and Gender Minorities</subject><subject>Sexual Dysfunction, Urinary Incontinence</subject><subject>Surveys and Questionnaires</subject><issn>1743-6095</issn><issn>1743-6109</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kctq3DAYhUVpaC7tC2RRtEwWdnXxTRAKwTRNIKGhHroVsvw7o8G2EkkOmafoK1eDk9BmUW0k-M_5JJ2D0DElKSW0-LJJN_5pTBlhNKUsJZS9Qwe0zHhSUCLev5yJyPfRofcbQnhc7APa5znllApxgH7XDlQwdsJq6vCt3-q1HSE4o_EvNZhumdkehzXgBp5mNeAbM1lnggG_mJz1QQXAtZo0ONxoNQA-aW7O6-YUm-mNbYtvIxSm4JNVZP4EH6yDhOEmzN32I9rr1eDh0_N-hFYX31b1ZXL94_tVfX6d6CzPQ1KWLRfQ5hm0TFSEF0UuBOv6ktCeA2k56UquCWNlVWWkrWIIFBSUQCBrueJH6OuCvZ_bETodn-PUIO-dGZXbSquM_HcymbW8s4-yqgTntIyAk2eAsw9z_IMcjdcwDGoCO3vJClZUgsSYo5QtUh2D8g7612sokbsi5UbuipS7IiVlMhYZTZ__fuCr5aW5KDhbBBBTejTgpNcxVQ2dcaCD7Kz5H_8PYj6w7Q</recordid><startdate>20220301</startdate><enddate>20220301</enddate><creator>Polter, Elizabeth J.</creator><creator>Kohli, Nidhi</creator><creator>Rosser, B.R. Simon</creator><creator>Talley, Kristine M.C.</creator><creator>Wheldon, Christopher W.</creator><creator>Hoefer, Chris J.</creator><creator>Wright, Morgan</creator><creator>Haggart, Ryan</creator><creator>Mitteldorf, Darry</creator><creator>Kilian, Gudrun</creator><creator>Konety, Badrinath R.</creator><creator>Ross, Michael W.</creator><creator>West, William</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220301</creationdate><title>Creation and Psychometric Validation of the Sexual Minorities and Prostate Cancer Scale (SMACS) in Sexual Minority Patients-The Restore-2 Study</title><author>Polter, Elizabeth J. ; Kohli, Nidhi ; Rosser, B.R. Simon ; Talley, Kristine M.C. ; Wheldon, Christopher W. ; Hoefer, Chris J. ; Wright, Morgan ; Haggart, Ryan ; Mitteldorf, Darry ; Kilian, Gudrun ; Konety, Badrinath R. ; Ross, Michael W. ; West, William</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-77b39eb54eb29803665992df701f3e0b30d73c02278840b86091eae7e0e4b3a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Humans</topic><topic>Male</topic><topic>Men</topic><topic>Prostate Cancer</topic><topic>Prostatic Neoplasms - diagnosis</topic><topic>Psychometric</topic><topic>Psychometrics</topic><topic>Quality of Life</topic><topic>Reproducibility of Results</topic><topic>Sexual and Gender Minorities</topic><topic>Sexual Dysfunction, Urinary Incontinence</topic><topic>Surveys and Questionnaires</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Polter, Elizabeth J.</creatorcontrib><creatorcontrib>Kohli, Nidhi</creatorcontrib><creatorcontrib>Rosser, B.R. Simon</creatorcontrib><creatorcontrib>Talley, Kristine M.C.</creatorcontrib><creatorcontrib>Wheldon, Christopher W.</creatorcontrib><creatorcontrib>Hoefer, Chris J.</creatorcontrib><creatorcontrib>Wright, Morgan</creatorcontrib><creatorcontrib>Haggart, Ryan</creatorcontrib><creatorcontrib>Mitteldorf, Darry</creatorcontrib><creatorcontrib>Kilian, Gudrun</creatorcontrib><creatorcontrib>Konety, Badrinath R.</creatorcontrib><creatorcontrib>Ross, Michael W.</creatorcontrib><creatorcontrib>West, William</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of sexual medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Polter, Elizabeth J.</au><au>Kohli, Nidhi</au><au>Rosser, B.R. Simon</au><au>Talley, Kristine M.C.</au><au>Wheldon, Christopher W.</au><au>Hoefer, Chris J.</au><au>Wright, Morgan</au><au>Haggart, Ryan</au><au>Mitteldorf, Darry</au><au>Kilian, Gudrun</au><au>Konety, Badrinath R.</au><au>Ross, Michael W.</au><au>West, William</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Creation and Psychometric Validation of the Sexual Minorities and Prostate Cancer Scale (SMACS) in Sexual Minority Patients-The Restore-2 Study</atitle><jtitle>Journal of sexual medicine</jtitle><addtitle>J Sex Med</addtitle><date>2022-03-01</date><risdate>2022</risdate><volume>19</volume><issue>3</issue><spage>529</spage><epage>540</epage><pages>529-540</pages><issn>1743-6095</issn><eissn>1743-6109</eissn><abstract>Existing measures of sexual functioning in prostate cancer survivors focus primarily on erectile function and do not adequately measure the experiences of sexual minority men. To develop and psychometrically evaluate a new scale to measure sexual functioning among sexual minority men with prostate cancer. Sexual minority prostate cancer patients (n = 401) completed an online battery of urinary and sexual functioning tests in 2019, including a new 37-item instrument about their sexual functioning post-treatment for prostate cancer. We used confirmatory factor analysis to determine the construct validity of a new scale including five subscales: a four-factor model for all participants (n = 401) evaluated Sexual Satisfaction, Sexual Confidence, Frequency of Sexual Problems, and Urinary Incontinence in Sex. A single-factor model completed only by participants who had attempted or desired receptive anal sex (n = 255) was evaluated in the fifth subscale: Problematic Receptive Anal Sex. To evaluate criterion validity, we calculated the intercorrelations between each Sexual Minorities and Prostate Cancer Scale (SMACS) subscale and four related scales: the Expanded Prostate Cancer Index Composite-50 (EPIC), the Functional Assessment of Cancer Therapy-Prostate, the Brief Symptom Inventory-18, and the International Consultation on incontinence questionnaire. Cronbach's alphas were calculated to measure internal consistency (ie, reliability). Cronbach's alpha values ranged from 0.64 to 0.89. Loadings (0.479–0.926) and model fit indices were strong (Root Mean Square Error of Approximation: 0.085, Standardized root mean squared residual: 0.063, comparative fit index: 0.927, Tucker-Lewis Index: 0.907). For criterion validity, Sexual Satisfaction, Sexual Confidence, and Frequency of Sexual Problems were moderately correlated with EPIC function and bother scores (r = 0.50–0.72) and Urinary incontinence in sex correlated moderately with EPIC Urinary Function and International Consultation on incontinence questionnaire scores (0.45–0.56). The SMACS can be used by clinicians and researchers to comprehensively measure sexual functioning in sexual minority men, in conjunction with existing scales. This new scale is validated in a large, geographically diverse cohort of sexual minority cancer survivors and fills an important gap in existing measures of sexual functioning. Limitations include a lack of a validation sample. The SMACS is a valid and reliable new scale that measures sexual minority men's experience of urinary incontinence in sex, problematic receptive anal sex, and sexual distress. Polter EJ, Kohli N, Rosser BRS, et al. Creation and Psychometric Validation of the Sexual Minorities and Prostate Cancer Scale (SMACS) in Sexual Minority Patients-The Restore-2 Study. J Sex Med 2022;19:529–540.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>35131199</pmid><doi>10.1016/j.jsxm.2021.12.012</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1743-6095
ispartof Journal of sexual medicine, 2022-03, Vol.19 (3), p.529-540
issn 1743-6095
1743-6109
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8893317
source Oxford University Press Journals All Titles (1996-Current); MEDLINE
subjects Humans
Male
Men
Prostate Cancer
Prostatic Neoplasms - diagnosis
Psychometric
Psychometrics
Quality of Life
Reproducibility of Results
Sexual and Gender Minorities
Sexual Dysfunction, Urinary Incontinence
Surveys and Questionnaires
title Creation and Psychometric Validation of the Sexual Minorities and Prostate Cancer Scale (SMACS) in Sexual Minority Patients-The Restore-2 Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T22%3A28%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Creation%20and%20Psychometric%20Validation%20of%20the%20Sexual%20Minorities%20and%20Prostate%20Cancer%20Scale%20(SMACS)%20in%20Sexual%20Minority%20Patients-The%20Restore-2%20Study&rft.jtitle=Journal%20of%20sexual%20medicine&rft.au=Polter,%20Elizabeth%20J.&rft.date=2022-03-01&rft.volume=19&rft.issue=3&rft.spage=529&rft.epage=540&rft.pages=529-540&rft.issn=1743-6095&rft.eissn=1743-6109&rft_id=info:doi/10.1016/j.jsxm.2021.12.012&rft_dat=%3Cproquest_pubme%3E2626890131%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2626890131&rft_id=info:pmid/35131199&rft_els_id=S1743609521008328&rfr_iscdi=true